Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

emcure pharma

Tag: emcure pharma

Read all Latest developments, information and news on and about emcure pharma - Page 2

Emcure Pharma is an Indian pharmaceutical company headquartered in Pune, Maharashtra. Emcure's product portfolio includes tablets, capsules, and injectables.

Emcure Pharma inaugurates RnD centre in Gujarat

Ruchika Sharma23 Jan 2025 11:00 AM IST

Ahmedabad: Emcure Pharmaceuticals Limited has announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre...

Keshav Bhutada becomes CEO of Shilpa Pharma Life Sciences

Gufic Biosciences appoints Dr Kathiresan Rajasekar as President - International Business, Senior Management Personnel

Ruchika Sharma17 Jan 2025 1:50 PM IST

Karnataka: Gufic Biosciences has announced the appointment of Dr Kathiresan Rajasekar as President – International Business, Senior Management...

Shares of Emcure Pharma surges over 31 percent in debut trade

Ruchika Sharma11 July 2024 12:30 PM IST

New Delhi: Shares of Emcure Pharmaceuticals Ltd made a debut on Wednesday as they listed with a significant premium of over 31 percent against...

Emcure Pharma set to launch IPO on July 3

Ruchika Sharma30 Jun 2024 10:15 AM IST

Emcure Pharmaceuticals, backed by Bain Capital, is set to float its Initial Public Offering (IPO) on July 3. The initial share sale will run until...

Emcure Pharma receives SEBI nod to float IPO

Ruchika Sharma25 Jun 2024 3:49 PM IST

Emcure Pharmaceuticals, backed by Bain Capital has received approval from Securities and Exchange Board of India's (SEBI) to raise...

Batch of Telma AM earlier classified as NSQ now flagged as Spurious

CDSCO declares 5 formulations as spurious: Details

Dr. Divya Colin17 Jun 2024 6:00 PM IST

New Delhi: In the latest spurious drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has declared 5...

Merck injected version of Keytruda faces possible patent challenge: Report

Emcure Pharma, Gennova Biopharma resolves all legal disputes with HDT Bio

Ruchika Sharma23 May 2024 5:48 PM IST

Pune: Emcure Pharmaceuticals Ltd. and its biotech subsidiary, Gennova Biopharmaceuticals Ltd. have amicably resolved all legal disputes with HDT...

Sanofi concludes acquisition of Blueprint Medicines

Sanofi India, Emcure Pharma forge exclusive partnership for cardiovascular product distribution

Ruchika Sharma13 March 2024 5:30 PM IST

Emcure Pharmaceuticals will exclusively distribute and promote the Company's Cardiovascular range of products that include well-established brands...

Emcure wins dismissal of US lawsuit over COVID vaccine trade secrets

Ruchika Sharma7 Dec 2023 2:42 PM IST

The lawsuit said that HDT licensed its technology to Emcure subsidiary Gennova Biopharmaceuticals to develop and sell the vaccine in India. HDT...

Substandard Drugs Flagged Across Multiple States, Over 130 Batches Fail Quality Tests In April

CDSCO Drug Alert: 61 Drug Samples Including Emcure's Levocarnitine Inj Flagged

Dr. Divya Colin24 Nov 2023 6:00 PM IST

New Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 61 medicine...

Emcure Pharma Expands Its Dermatology Portfolio

Emcure Pharma aims to raise USD 400- USD 500 million from IPO planned for next year

Ruchika Sharma26 Sept 2023 2:34 PM IST

India's pharmaceuticals market is expected to reach USD 130 billion in 2030 from USD 50 billion currently, and deal-making in the sector is booming.

Emcure gets CDSCO Panel Nod To Manufacture, Market ferric Carboxymaltose injection 50mg/ml

Dr. Divya Colin25 Sept 2023 6:00 PM IST

New Delhi: Emcure Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok